PCP prophylaxis with use of corticosteroids by neurologists.
Pneumocystis jirovecii pneumonia (PCP) is increasingly reported in patients without HIV. Corticosteroids are a major risk factor, with up to 90% of patients receiving corticosteroid treatment prior to the development of PCP. In view of this, many specialties now prescribe PCP prophylaxis to patients receiving prolonged or high-dose glucocorticoid regimens. Neurologists frequently prescribe corticosteroids but may not be as aware of the risk for PCP. Here, we review the evidence for routine PCP prophylaxis among regular glucocorticoid users and ask what guidance there is on the subject for neurologists.
Department of Neurology, Cork University Hospital, , Cork, Ireland.
Dearbhla M
DM
Kelly
Simon
S
Cronin
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use*; D006801:Humans; D009462:Neurology; D010820:Physicians / Q000706:statistics & numerical data; D045363:Pneumocystis carinii / Q000187:drug effects / Q000472:pathogenicity; D011020:Pneumonia, Pneumocystis / Q000517:prevention & control*
D000305:Adrenal Cortex Hormones
CLINICAL NEUROLOGY; STEROIDS